Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.280
-0.180 (-5.20%)
At close: Jun 2, 2026, 4:00 PM EDT
3.261
-0.019 (-0.59%)
After-hours: Jun 2, 2026, 7:58 PM EDT
Ironwood Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Ironwood Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.10. The average 1-year stock price forecast is 85.98% higher than the current stock price, while the lowest is $3.70 (+12.80%) and the highest is $10 (+204.88%).
Price Target: $6.10 (+85.98%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ironwood Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Jan '26 | Feb '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 5 | 5 | 4 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $5 | Hold | Maintains | $5 | +52.44% | May 6, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +204.88% | Feb 26, 2026 |
Financial Forecast
Revenue This Year
459.48M
from 296.15M
Increased by 55.15%
Revenue Next Year
478.35M
from 459.48M
Increased by 4.11%
EPS This Year
1.18
from 0.15
Increased by 695.16%
EPS Next Year
1.24
from 1.18
Increased by 4.66%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 463.5M | ||
| Avg | 459.5M | ||
| Low | 452.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 56.5% | ||
| Avg | 55.1% | ||
| Low | 52.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.23 | ||
| Avg | 1.18 | ||
| Low | 1.13 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 728.9% | ||
| Avg | 695.2% | ||
| Low | 661.5% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.